Matrix & Growth-Factor Peptides

CJC-1295 / Ipamorelin 8mg / 8mg

$105

This product is intended for research purposes only. Not intended for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you acknowledge that you are a qualified researcher and understand the nature of this product.

This vial is a two-component co-lyophilized preparation containing 8mg of CJC-1295 (modified GRF 1-29), a 30-amino acid GHRH analogue, and 8mg of the pentapeptide Ipamorelin.

CJC-1295 / IpamorelinMatrix & Growth-Factor Peptides

Overview

CJC-1295 in this preparation is the no-DAC variant, also called modified GRF 1-29: a 30-amino acid analogue of growth hormone-releasing hormone bearing four substitutions (D-Ala at position 2, Gln at 8, Ala at 15, Leu at 27) that reduce cleavage by dipeptidyl peptidase IV.

Ipamorelin is a pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, and an agonist at the ghrelin receptor GHSR-1a. The two peptides are present at 8mg each and were lyophilized together, so the mass ratio in the vial is fixed.

Mechanism of Action

CJC-1295 binds the growth hormone-releasing hormone receptor (GHRHR), a class B G protein-coupled receptor; Ipamorelin is an agonist at the ghrelin receptor GHSR-1a, a class A G protein-coupled receptor.

Certificates of Analysis1

Independent third-party lab reports for this peptide. Each CoA can be verified against its accession number at the testing lab.

1 independent test by Freedom Diagnostics Testing

TestResult
Purity (HPLC)99.676%
Identity (MS)Pass
Endotoxins (LAL)Pass

Lab: Freedom Diagnostics Testing

Accession: 2604020226

Reports are verifiable against the issuing lab using the accession or batch identifier above.

Other compounds in the matrix & growth-factor peptides category.